Rafat Abonour

  • 3552 Citations
  • 30 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

  • 3552 Citations
  • 30 h-Index
  • 78 Article
  • 8 Review article
  • 5 Letter
  • 3 Comment/debate
2020

Connect MM Registry as a national reference for United States multiple myeloma patients

on behalf of Connect MM Registry Investigators, Jan 1 2020, In : Cancer Medicine. 9, 1, p. 35-42 8 p.

Research output: Contribution to journalArticle

Open Access
Open Access

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases

Kalra, M., Adra, N., Hanna, N., Abonour, R. & Einhorn, L. H., Mar 15 2020, In : Cancer. 126, 6, p. 1202-1207 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

Gavriatopoulou, M., Chari, A., Chen, C., Bahlis, N., Vogl, D. T., Jakubowiak, A., Dingli, D., Cornell, R. F., Hofmeister, C. C., Siegel, D., Berdeja, J. G., Reece, D., White, D., Lentzsch, S., Gasparetto, C., Huff, C. A., Jagannath, S., Baz, R., Nooka, A. K., Richter, J. & 17 others, Abonour, R., Parker, T. L., Yee, A. J., Moreau, P., Lonial, S., Tuchman, S., Weisel, K. C., Mohty, M., Choquet, S., Unger, T. J., Li, K., Chai, Y., Li, L., Shah, J., Shacham, S., Kauffman, M. G. & Dimopoulos, M. A., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors

Zhang, K. J., Hanna, N. H., Althouse, S. K., Zaid, M. A., Abonour, R., Albany, C., Einhorn, L. H. & Adra, N., Jan 1 2020, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalComment/debate

Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry

CONNECT MM Registry Investigators, May 2020, In : Clinical Lymphoma, Myeloma and Leukemia. 20, 5, p. 272-276 5 p.

Research output: Contribution to journalComment/debate

Open Access
2019

Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry

on behalf of the CONNECT MM Registry Investigators, Dec 1 2019, In : British journal of haematology. 187, 5, p. 602-614 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

High-Dose Chemotherapy and Autologous Stem Cell Transplant

Adra, N. & Abonour, R., Aug 2019, In : Urologic Clinics of North America. 46, 3, p. 439-448 10 p.

Research output: Contribution to journalReview article

2018

Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients

Adams, R. N., Mosher, C. E., Winger, J. G., Abonour, R. & Kroenke, K., Apr 1 2018, In : Journal of Behavioral Medicine. 41, 2, p. 243-252 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)

Jagannath, S., Abonour, R., Durie, B. G. M., Gasparetto, C., Hardin, J. W., Narang, M., Terebelo, H. R., Toomey, K., Wagner, L., Srinivasan, S., Kitali, A., Yue, L., Flick, E. D., Agarwal, A. & Rifkin, R. M., Jul 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 7, p. 480-485.e3

Research output: Contribution to journalArticle

6 Scopus citations

Impact of initial treatment (tx) on HRQoL and outcomes in patients (pts) with newly diagnosed multiple myeloma (NDMM) without intent for immediate transplant (SCT): Results from the Connect® MM registry

Abonour, R., Rifkin, R. M., Gasparetto, C., Toomey, K., Durie, B. G. M., Hardin, J. W., Terebelo, H. R., Jagannath, S., Narang, M., Ailawadhi, S., Srinivasan, S., Kitali, A., Agarwal, A. & Wagner, L., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii360

Research output: Contribution to journalArticle

Open Access

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in connect MM

Jagannath, S., Abonour, R., Durie, B. G. M., Narang, M., Terebelo, H. R., Gasparetto, C. J., Toomey, K., Hardin, J. W., Wagner, L., Agarwal, A., Srinivasan, S., Kitali, A., Dawn Flick, E., Sturniolo, M. & Rifkin, R. M., Jul 10 2018, In : Blood Advances. 2, 13, p. 1608-1615 8 p.

Research output: Contribution to journalArticle

Open Access
12 Scopus citations

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Abonour, R., Wagner, L., Durie, B. G. M., Jagannath, S., Narang, M., Terebelo, H. R., Gasparetto, C. J., Toomey, K., Hardin, J. W., Kitali, A., Gibson, C. J., Srinivasan, S., Swern, A. S. & Rifkin, R. M., Dec 1 2018, In : Annals of Hematology. 97, 12, p. 2425-2436 12 p.

Research output: Contribution to journalArticle

8 Scopus citations

Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma

Vogl, D. T., Dingli, D., Cornell, R. F., Huff, C. A., Jagannath, S., Bhutani, D., Zonder, J., Baz, R., Nooka, A., Richter, J., Cole, C., Vij, R., Jakubowiak, A., Abonour, R., Schiller, G., Parker, T. L., Costa, L. J., Kaminetzky, D., Hoffman, J. E., Yee, A. J. & 12 others, Chari, A., Siegel, D., Fonseca, R., Van Wier, S., Ahmann, G., Lopez, I., Kauffman, M., Shacham, S., Saint-Martin, J. R., Picklesimer, C. D., Choe-Juliak, C. & Keith Stewart, A., Jan 1 2018, In : Journal of Clinical Oncology. 36, 9, p. 859-866 8 p.

Research output: Contribution to journalArticle

46 Scopus citations

Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry

Rifkin, R. M., Jagannath, S., Durie, B. G. M., Narang, M., Terebelo, H. R., Gasparetto, C. J., Toomey, K., Hardin, J. W., Wagner, L., Parikh, K., Abouzaid, S., Srinivasan, S., Kitali, A., Zafar, F. & Abonour, R., Jul 2018, In : Clinical Therapeutics. 40, 7, p. 1193-1202.e1

Research output: Contribution to journalReview article

3 Scopus citations
2017

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

Vadhan-Raj, S., Abonour, R., Goldman, J. W., Smith, D. A., Slapak, C. A., Ilaria, R. L., Tiu, R. V., Wang, X., Callies, S., Cox, J., Tuttle, J. L., Lau, Y. K. & Roeland, E. J., Mar 21 2017, In : Journal of Hematology and Oncology. 10, 1, 73.

Research output: Contribution to journalArticle

15 Scopus citations

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes

Shah, J. J., Abonour, R., Gasparetto, C., Hardin, J. W., Toomey, K., Narang, M., Srinivasan, S., Kitali, A., Zafar, F., Flick, E. D. & Rifkin, R. M., Sep 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 9, p. 575-583.e2

Research output: Contribution to journalArticle

16 Scopus citations

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes

Hari, P., Mateos, M. V., Abonour, R., Knop, S., Bensinger, W., Ludwig, H., Song, K., Hajek, R., Moreau, P., Siegel, D. S., Feng, S., Obreja, M., Aggarwal, S. K., Iskander, K. & Goldschmidt, H., Dec 1 2017, In : Leukemia. 31, 12, p. 2630-2641 12 p.

Research output: Contribution to journalArticle

9 Scopus citations
51 Scopus citations

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S. S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., Jan 1 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Recognition of early mortality in multiple myeloma by a prediction matrix

Terebelo, H., Srinivasan, S., Narang, M., Abonour, R., Gasparetto, C., Toomey, K., Hardin, J. W., Larkins, G., Kitali, A., Rifkin, R. M. & Shah, J. J., Sep 2017, In : American Journal of Hematology. 92, 9, p. 915-923 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

The Cancer Loneliness Scale and Cancer-related Negative Social Expectations Scale: development and validation

Adams, R. N., Mosher, C. E., Rand, K. L., Hirsh, A. T., Monahan, P. O., Abonour, R. & Kroenke, K., Jul 1 2017, In : Quality of Life Research. 26, 7, p. 1901-1913 13 p.

Research output: Contribution to journalArticle

4 Scopus citations
2016

Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma

Xu, L., Mohammad, K. S., Wu, H., Crean, C., Poteat, B., Cheng, Y., Cardoso, A. A., Machal, C., Hanenberg, H., Abonour, R., Kacena, M. A., Chirgwin, J., Suvannasankha, A. & Srour, E. F., Dec 1 2016, In : Cancer Research. 76, 23, p. 6901-6910 10 p.

Research output: Contribution to journalArticle

6 Scopus citations

Cognitive and situational precipitants of loneliness among patients with cancer: A qualitative analysis

Adams, R. N., Mosher, C. E., Abonour, R., Robertson, M. J., Champion, V. L. & Kroenke, K., Mar 2016, In : Oncology nursing forum. 43, 2, p. 156-163 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Rifkin, R. M., Abonour, R., Shah, J. J., Mehta, J., Narang, M., Terebelo, H., Gasparetto, C., Toomey, K., Hardin, J. W., Lu, J. J., Kenvin, L., Srinivasan, S., Knight, R., Nagarwala, Y. & Durie, B. G. M., Sep 1 2016, In : Leukemia and Lymphoma. 57, 9, p. 2228-2231 4 p.

Research output: Contribution to journalLetter

14 Scopus citations

Disease-free survival following high dose or standard dose therapy in patients with amyloidosis

Kiel, P. J., Trueg, A. O., Ferguson, M., Benson, M. & Abonour, R., Jul 1 2016, In : British journal of haematology. 174, 1, p. 153-155 3 p.

Research output: Contribution to journalLetter

3 Scopus citations

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: Long-term follow-up

Biran, N., Jacobus, S., Vesole, D. H., Callander, N. S., Fonseca, R., Williams, M. E., Abonour, R., Katz, M. S., Rajkumar, S. V., Greipp, P. R. & Siegel, D. S., Sep 2 2016, In : Blood Cancer Journal. 6, 9, e466.

Research output: Contribution to journalArticle

7 Scopus citations

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia

Boyiadzis, M., Bishop, M. R., Abonour, R., Anderson, K. C., Ansell, S. M., Avigan, D., Barbarotta, L., Barrett, A. J., Besien, K., Bergsagel, P. L., Borrello, I., Brody, J., Brufsky, J., Cairo, M., Chari, A., Cohen, A., Cortes, J., Forman, S. J., Friedberg, J. W., Fuchs, E. J. & 28 others, Gore, S. D., Jagannath, S., Kahl, B. S., Kline, J., Kochenderfer, J. N., Kwak, L. W., Levy, R., Lima, M., Litzow, M. R., Mahindra, A., Miller, J., Munshi, N. C., Orlowski, R. Z., Pagel, J. M., Porter, D. L., Russell, S. J., Schwartz, K., Shipp, M. A., Siegel, D., Stone, R. M., Tallman, M. S., Timmerman, J. M., Rhee, F., Waller, E. K., Welsh, A., Werner, M., Wiernik, P. H. & Dhodapkar, M. V., Dec 20 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 90.

Research output: Contribution to journalArticle

6 Scopus citations
2015

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

Giralt, S., Garderet, L., Durie, B., Cook, G., Gahrton, G., Bruno, B., Hari, P., Lokhorst, H., McCarthy, P., Krishnan, A., Sonneveld, P., Goldschmidt, H., Jagannath, S., Barlogie, B., Mateos, M., Gimsing, P., Sezer, O., Mikhael, J., Lu, J., Dimopoulos, M. & 45 others, Mazumder, A., Palumbo, A., Abonour, R., Anderson, K., Attal, M., Blade, J., Bird, J., Cavo, M., Comenzo, R., de la Rubia, J., Einsele, H., Garcia-Sanz, R., Hillengass, J., Holstein, S., Johnsen, H. E., Joshua, D., Koehne, G., Kumar, S., Kyle, R., Leleu, X., Lonial, S., Ludwig, H., Nahi, H., Nooka, A., Orlowski, R., Rajkumar, V., Reiman, A., Richardson, P., Riva, E., San Miguel, J., Turreson, I., Usmani, S., Vesole, D., Bensinger, W., Qazilbash, M., Efebera, Y., Mohty, M., Gasparreto, C., Gajewski, J., LeMaistre, C. F., Bredeson, C., Moreau, P., Pasquini, M., Kroeger, N. & Stadtmauer, E., Dec 2015, In : Biology of Blood and Marrow Transplantation. 21, 12, p. 2039-2051 13 p.

Research output: Contribution to journalReview article

90 Scopus citations

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma

Shah, J. J., Stadtmauer, E. A., Abonour, R., Cohen, A. D., Bensinger, W. I., Gasparetto, C., Kaufman, J. L., Lentzsch, S., Vogl, D. T., Gomes, C. L., Pascucci, N., Smith, D. D., Orlowski, R. Z. & Durie, B. G. M., Nov 12 2015, In : Blood. 126, 20, p. 2284-2290 7 p.

Research output: Contribution to journalArticle

143 Scopus citations

Connect MM registry: The importance of establishing baseline disease characteristics

Rifkin, R. M., Abonour, R., Terebelo, H., Shah, J. J., Gasparetto, C., Hardin, J., Srinivasan, S., Ricafort, R., Nagarwala, Y. & Durie, B. G. M., Jun 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 6, p. 368-376 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors

Ammakkanavar, N. R., Matei, D., Abonour, R. & Einhorn, L. H., Oct 10 2015, In : Journal of Clinical Oncology. 33, 2, p. 226-227 2 p.

Research output: Contribution to journalLetter

15 Scopus citations

Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?

Fawole, A., Abonour, R., Stender, M., Shatavi, S., Gaikazian, S., Anderson, J. & Jaiyesimi, I., Jan 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 34-41 8 p.

Research output: Contribution to journalReview article

1 Scopus citations
2013

Children's emotional adaptation to parental BMT

Spath, M. L., Fife, B. L., Monahan, P. O., Decker, C. L., Austin, J. K., Abonour, R. & Wood, L. L., Jan 1 2013, In : Bone marrow transplantation. 48, 1, p. 135-140 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

Farag, S. S., Srivastava, S., Messina-Graham, S., Schwartz, J., Robertson, M. J., Abonour, R., Cornetta, K., Wood, L., Secrest, A., Strother, R. M., Jones, D. R. & Broxmeyer, H. E., Apr 1 2013, In : Stem Cells and Development. 22, 7, p. 1007-1015 9 p.

Research output: Contribution to journalArticle

70 Scopus citations
9 Scopus citations
2012

Aphase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., Caligiuri, M. A. & Farag, S. S., Nov 22 2012, In : Blood. 120, 22, p. 4324-4333 10 p.

Research output: Contribution to journalArticle

144 Scopus citations

Novel combination treatments targeting chronic myeloid leukemia stem cells

Al Baghdadi, T., Abonour, R. & Boswell, H. S., Apr 1 2012, In : Clinical Lymphoma, Myeloma and Leukemia. 12, 2, p. 94-105 12 p.

Research output: Contribution to journalReview article

15 Scopus citations

Observations of second primary malignancy in patients with multiple myeloma

Ormerod, A., Fausel, C. A., Abonour, R. & Kiel, P. J., Apr 1 2012, In : Clinical Lymphoma, Myeloma and Leukemia. 12, 2, p. 113-117 5 p.

Research output: Contribution to journalArticle

9 Scopus citations

Palifermin for the reduction of acute GVHD: A randomized, double-blind, placebo-controlled trial

Jagasia, M. H., Abonour, R., Long, G. D., Bolwell, B. J., Laport, G. G., Shore, T. B., Durrant, S., Szer, J., Chen, M. G., Lizambri, R. & Waller, E. K., Oct 1 2012, In : Bone Marrow Transplantation. 47, 10, p. 1350-1355 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

Wolf, J. L., Siegel, D., Goldschmidt, H., Hazell, K., Bourquelot, P. M., Bengoudifa, B. R., Matous, J., Vij, R., De Magalhaes-Silverman, M., Abonour, R., Anderson, K. C. & Lonial, S., Sep 1 2012, In : Leukemia and Lymphoma. 53, 9, p. 1820-1823 4 p.

Research output: Contribution to journalLetter

100 Scopus citations
2011

Antisense oligonucleotide therapy for TTR amyloidosis

Benson, M., Pandey, S., Abonour, R., Jazayeri, A., Siwkowski, A., Monia, B. & Kluve-Beckerman, B., Jun 2011, In : Amyloid. 18, SUPPL. 1, p. 60 1 p.

Research output: Contribution to journalArticle

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

Ghobrial, I. M., Munshi, N. C., Harris, B. N., Shi, P., Porter, N. M., Schlossman, R. L., Laubach, J. P., Anderson, K. C., Desaiah, D., Myrand, S. P., Wooldridge, J. E., Richardson, P. G. & Abonour, R., Jul 1 2011, In : American Journal of Hematology. 86, 7, p. 573-578 6 p.

Research output: Contribution to journalArticle

22 Scopus citations

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R. P., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. J. & Farag, S. S., Jul 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience

Abonour, R., Kramer, G., Suvannasankha, A. & Benson, M. D., Jun 2011, In : Amyloid. 18, SUPPL. 1, 1 p.

Research output: Contribution to journalArticle

2 Scopus citations

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia

Farag, S. S., Wood, L. L., Schwartz, J. E., Srivastava, S., Nelson, R. P., Robertson, M. J., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K. & Jones, D. R., Apr 2011, In : Leukemia. 25, 4, p. 599-605 7 p.

Research output: Contribution to journalArticle

Open Access
28 Scopus citations

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation

Rosenbeck, L. L., Kiel, P. J., Kalsekar, I., Vargo, C., Baute, J., Sullivan, C. K., Wood, L., Abdelqader, S., Schwartz, J., Srivastava, S., Abonour, R., Robertson, M. J., Nelson, R. P., Cornetta, K., Fausel, C. A. & Farag, S. S., Jun 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 6, p. 916-922 7 p.

Research output: Contribution to journalArticle

23 Scopus citations
13 Scopus citations